Pfizer Inc. elected Dan Littman to the board.
Littman is a professor of molecular immunology at Skirball Institute of Biomolecular Medicine of NYU Langone Medical Center and an investigator of the Howard Hughes Medical Institute.
Pfizer elects board member
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Pfizer Inc. elected Dan Littman to the board.
Littman is a professor of molecular immunology at Skirball Institute of Biomolecular Medicine of NYU Langone Medical Center and an investigator of the Howard Hughes Medical Institute.